|
REFERENCES
1.) Hirabayashi Y, Furuya S. Roles of l-serine and sphingolipid synthesis in
brain development and neuronal survival. Prog Lipid Res. 2008 Feb 15 [Epub ahead
of print].
2.) Vance JE. Phosphatidylserine and phosphatidylethanolamine in mammalian
cells: two metabolically-related aminophospholipids. J Lipid Res. 2008 Jan 19 [Epub
ahead of print]
3.) Cenacchi, B, Bertoldin T, Farina C, Fiori M.G., Crepaldi G. Cognitive
decline in the elderly: a double-blind, placebo-controlled multicenter study on
efficacy of phosphatidylserine administration. Aging (Clin. Exp. Res.), 1993, 5:
123-33.
4.) Crook, T.H., Tinklenburg, J, Yesavage J, Petrie W, Nunzie M.G., and Massari,
D.C. Effects of phosphatidylserine in age-associated memory impairment. Neurol,
1991. 41: 644-9.
5.) Gindin, J, et al., 1995. The Effect of Plant Phosphatidylserine on
Age-Associated Memory Impairment and Mood in the Functioning Elderly. Rehovot,
Israel: Geriatric Institute for Education and Research, and Department of
Geriatrics, Kaplan Hospital.
6.) Amaducci, L and the SMID Group. Phosphatidylserine in the treatment of
Alzheimers disease: results of a multicenter study. Psychopharmacol. Bulletin,
1988, 24: 130-4.
7.) Cenacchi, B, Bertoldin T, Farina C, Fiori M.G., Crepaldi G. Cognitive
decline in the elderly: a double-blind, placebo-controlled multicenter study on
efficacy of phosphatidylserine administration. Aging (Clin. Exp. Res.), 1993, 5:
123-33.
8.) Crook, T.H., Tinklenburg, J, Yesavage J, Petrie W, Nunzie M.G., and Massari,
D.C. Effects of phosphatidylserine in age-associated memory impairment. Neurol,
1991. 41: 644-9.
9.) Crook, T.H., Petrie W, Wells C, Massari, D.C. Effects of phosphatidylserine
in Alzheimers disease. Psychopharmacol. Bulletin,, 1992. 28: 61-6.
10.) Delwaide, P.J., Gyselynk-Mambourg A.M., Hurlet A. and Ylieff M.
Double-blind randomized controlled study of phosphatidylserine in demented
patients. Acta Neurol. Scand, 1986. 73:136-40.
11.) Engel, R.R., Satzger W, Gunther W, Kathmann N, Bove D, Gerkes, Munch U and
Hippius H. Double-blind cross-over study of phosphatidylserine vs. placebo in
subjects with early cognitive deterioration of the Alzheimer type. Eur.
Neuropsychopharmacol, 1992. 2: 149-55.
12.) Funfgeld, E.W., Baggen, M, Nedwidek,P, et al. Double-blind study with
phosphatidylserine (PS) in Parkinsonian patients with senile dementia of
Alzheimers type (SDAT). Progr. Clin. Biol. Res, 1989. 317: 1235-46.
13.) Gindin, J, et al., 1995. The Effect of Plant Phosphatidylserine on
Age-Associated Memory Impairment and Mood in the Functioning Elderly. Rehovot,
Israel: Geriatric Institute for Education and Research, and Department of
Geriatrics, Kaplan Hospital.
14.) Hershowitz M, et al. Long-term treatment of dementia Alzheimer type with
phosphatidylserine: effect on cognitive functioning and performance in daily
life. In, Bazan NG, et al (eds) Phospholipids in the Nervous System: Biochemical
and Molecular Pathology, 1989. Padua, Italy: Liviana Press.
15.) Maggioni, M, Picotti, G.B., Bondiolotti ,G.P., Panerai, A. Cenacchi, T.
Nobil, P. and Brambilla, F. Effects of phosphatidylserine therapy in geriatric
patients with depressive disorders. Acta Psychiatr. Scand. 1990. 81: 265-70.
16.) Rosadini, G, Sannita ,W.G., Nobili, F, and Cenacchi, T. Phosphatidylserine:
quantitative EEG effects in healthy volunteers. Neuropsychobiol, 1991. 24: 42-8.
17.) Villardita, C, Griolis, S, Salmeri, G,et al.Multicentre clinical trial of
brain phosphatidylserine in elderly patients with intellectual deterioration.
Clin. Trials J., 1987. 24: 84-93.
18.) McDaniel MA, Maier SF, Einstein GO. (Nov-Dec 2003). "Brain-specific
nutrients: a memory cure?". Nutrition 19 (11-12): 957-75.
19.) Micheau J, Riedel G. (Apr 1999). "Protein kinases: which one is the memory
molecule?". Cell Mol Life Sci. 55 (4): 534-48.
20.) Monteleone, P, Beinat, L, Tanzillo,C, Maj, M, and Kemali, D. Effects of
phosphatidylserine on the neuroendocrine response to physical stress in humans.
Neuroendocrinol, 1990. 52: 243-8.
21.) Monteleone, P, Maj,M, Beinat,L, Natale,M, and Kemali,D. Blunting by chronic
phosphatidylserine administration of the stress-induced activation of the
hypothalamos-pituitary-adrenal axis in healthy men. Eur. J. Clin.Pharmacol,
1992. 41: 385-8. |
